NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
2.390
+0.020 (0.84%)
At close: Nov 6, 2025, 4:00 PM EST
2.410
+0.020 (0.84%)
After-hours: Nov 6, 2025, 4:10 PM EST
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $19.46 million as of November 6, 2025. Its market cap has decreased by -6.95% in one year.
Market Cap
19.46M
Enterprise Value
21.39M
1-Year Change
-6.95%
Ranking
Category
Stock Price
$2.39
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $19.59M to $19.46M, a decrease of -0.65%. That is a compound annual growth rate of -0.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 19.30M | -42.45% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
| Dec 22, 2021 | 19.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.29B |
| Johnson & Johnson | 449.33B |
| AbbVie | 381.76B |
| UnitedHealth Group | 298.64B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 214.66B |
| Thermo Fisher Scientific | 212.55B |